Activity-based Costing of Shared Decision-Making from Complicated Schizophrenic Patients in Psychiatric Pharmaceutical Care
Article Sidebar
Main Article Content
Abstract
Objective: To calculate unit cost of shared decision making from complicated schizophrenic patients in psychiatry pharmaceutical care using activity based costing at Nakhon Ratchasima Rajanagarindra Psychiatric Hospital. Methods: This research was a cross-sectional study collecting the information according to the record on patient-centered care towards integrated hospital medication management. Cost analysis was conducted from health service providers' perspective. Results: A total of 20 patients were divided into 17 males and 3 females. Participatory decisions took an average duration of 47.85 minutes (SD = 4.09) with cost of pharmacist labor at 2,921.09 baht (SD = 744.48), material cost at 6.97 baht (SD = 1.90) and investment cost at 11.19 baht (SD = 0.11). The total direct cost was 2,939.25 baht, the average cost of service was 146.96 baht. Sensitivity analysis with the change of wage of pharmacists revealed average cost of service per visit with low pharmacist's wages was 105.15 baht and 157.79 baht with high pharmacist's wages (mean 131.47, SD = 37.22). The patients were satisfied with service at the highest level without readmission to the hospital for re-treatment. Conclusion: The cost of shared decision-making by patients was 146.96 baht per time for complicated schizophrenic patients at risk of violence in community.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Kanjanasilp J, Ploylearmsang C. A short term outcomes of pharmaceutical care in Thai patients with schizophrenia: a randomized controlled trial. Songklanakarin J Sci Technol 2016;38: 189–97.
Samprasit N, Thavornwattanayong W. Outcome of pharmaceutical care in patients with psychiatric disorder: a systematic review. Journal of Health Systems Research. 2018;12: 590–607.
Rational Use of Drug Subcommittee. Teacher’s guide for promoting rational drug use. Nonthaburi: Food and Drug Administration, Ministry of Public Health; 2017.
Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: A model for clinical practice. J Gen Intern Med. 2012;27: 1361–7.
Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients : a randomised controlled study. BMC Psychiatry. 2015;15: 1–9.
Younas M, Bradley E, Holmes N, Sud D, Maidment ID. Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness. Int J Clin Pharm. 2016;38: 1191–9.
IHoMe Network, Faculty of Pharmaceutical Sciences Khon Kaen University and Udonthani Hospital. Khon Kaen: Integrated hospital medication management system (IHoMe). Khon Kaen: Khon Kaen University; 2017.
Riewpaiboon A. Standard cost lists for health technology assessment. Nonthaburi: Health Interven tion and Technology Assessment Program (HITAP); 2011.
Kessomboon N, Satja-areewat P. Financial manage ment for pharmacist: costing and investment decision on KhonKaen: Faculty of Pharmaceutical Sciences Khon Kaen University; 2009.
